TIPGENVI Trademark

Trademark Overview

On Wednesday, January 27, 2021, a trademark application was filed for TIPGENVI with the United States Patent and Trademark Office. The USPTO has given the TIPGENVI trademark a serial number of 90491494. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 7, 2024. This trademark is owned by Kura Oncology, Inc.. The TIPGENVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
tipgenvi

General Information

Serial Number90491494
Word MarkTIPGENVI
Filing DateWednesday, January 27, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKura Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameKura Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Saturday, January 30, 2021NEW APPLICATION ENTERED
Wednesday, April 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, August 15, 2021ASSIGNED TO EXAMINER
Wednesday, August 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 27, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, November 24, 2021OPPOSITION INSTITUTED NO. 999999
Tuesday, September 6, 2022OPPOSITION TERMINATED NO. 999999
Tuesday, September 6, 2022OPPOSITION DISMISSED NO. 999999
Tuesday, September 6, 2022TTAB RELEASE CASE TO TRADEMARKS
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 14, 2023SOU EXTENSION 1 FILED
Friday, April 14, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 2 FILED
Monday, September 25, 2023SOU EXTENSION 2 GRANTED
Tuesday, March 26, 2024SOU EXTENSION 3 FILED
Tuesday, March 26, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 26, 2024SOU EXTENSION 3 GRANTED
Monday, October 7, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024SOU EXTENSION 4 GRANTED
Monday, October 7, 2024SOU EXTENSION 4 FILED
Wednesday, March 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

tipgenvi cancer treatment products pharmaceutical